Hydroxychloroquine (400mg) h

Feb 06, 2024

Hydroxychloroquine (400mg)

HYDROQUIZ 400

Hydroquiz 400 is a pharmaceutical formulation containing Hydroxychloroquine (400 mg) as its active ingredient. Widely recognized for its therapeutic properties, Hydroxychloroquine is an antimalarial drug that also exhibits anti-inflammatory and immunomodulatory effects. This makes it a versatile medication used for various conditions, including malaria, autoimmune diseases, and more recently, some viral infections.

Composition

  • Active Ingredient: Hydroxychloroquine sulfate (400 mg)
  • Excipients: Typically includes binders, fillers, and coating agents (specific details may vary by manufacturer).

Mechanism of Action

Hydroxychloroquine works through multiple mechanisms:

  1. Antimalarial Activity: It interferes with the parasite's ability to metabolize and utilize hemoglobin, causing toxic build-up within the parasite.
  2. Immunomodulatory Effects: In autoimmune diseases, Hydroxychloroquine reduces inflammation by modulating the immune system, inhibiting cytokine production, and decreasing T-cell activation.
  3. Antiviral Potential: It affects viral replication by altering the pH within cells, making it harder for viruses to thrive.

Indications

Hydroquiz 400 is prescribed for a variety of conditions, including:

  1. Malaria
    • Treatment and prophylaxis of uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax.
  2. Autoimmune Disorders
    • Rheumatoid Arthritis (RA): Reduces joint inflammation and prevents disease progression.
    • Systemic Lupus Erythematosus (SLE): Mitigates skin, joint, and organ involvement in lupus.
    • Discoid Lupus Erythematosus (DLE): Treats chronic skin lesions.
  3. Other Off-Label Uses
    • Management of Sjögren’s syndrome.
    • Investigated for antiviral properties in conditions like COVID-19 (although its use remains controversial).

Dosage and Administration

  • Standard Dosage for Malaria:

    • Treatment: 800 mg (loading dose) on Day 1, followed by 400 mg at 6, 24, and 48 hours.
    • Prophylaxis: 400 mg weekly, starting 1-2 weeks before exposure and continuing for 4 weeks after leaving the malaria-endemic region.
  • Autoimmune Diseases:

    • 200–400 mg daily, adjusted according to patient weight and response.
  • Administration: Take with food or milk to minimize gastrointestinal side effects.

Side Effects

While generally well-tolerated, Hydroquiz 400 can cause side effects:

  1. Common
    • Nausea, vomiting, diarrhea.
    • Headache, dizziness.
    • Skin rash or itching.
  2. Serious
    • Retinopathy: Long-term use may lead to irreversible damage to the retina. Regular eye exams are essential.
    • Cardiotoxicity: Rarely, it may cause QT prolongation or arrhythmias.
    • Hypoglycemia: Can lower blood sugar levels, requiring close monitoring.
  3. Allergic Reactions
    • Angioedema, swelling, or difficulty breathing in rare cases.

Drug Interactions

Hydroquiz 400 may interact with:

  1. Anti-arrhythmics (e.g., Amiodarone): Risk of QT prolongation.
  2. Antiepileptics: May reduce seizure threshold.
  3. Antidiabetics: Enhanced hypoglycemic effect.
  4. Digoxin: Increases Digoxin levels.

Special Precautions

  1. Pregnancy: Use with caution, as Hydroxychloroquine crosses the placenta.
  2. Lactation: May pass into breast milk; consult a doctor.
  3. Pediatric Use: Dosage must be weight-based.
  4. Long-Term Use: Regular eye exams and monitoring of liver and kidney function are essential.

Clinical Significance

Hydroxychloroquine remains a cornerstone in the treatment of malaria and autoimmune conditions. Its ability to modulate the immune system has made it a key therapy for chronic inflammatory diseases. While its use in viral infections like COVID-19 has generated interest, it should only be prescribed within the guidelines of regulatory bodies to avoid misuse.

Conclusion

Hydroquiz 400, with its Hydroxychloroquine 400 mg composition, is a vital medication with diverse therapeutic applications. Patients should adhere strictly to prescribed dosages and consult their healthcare provider for any concerns. Proper monitoring and periodic evaluations ensure safe and effective use of this drug. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, SterisonlineSterisindia and Sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

BUY NOW

SHARE WITH